Document Detail


X-linked inhibitor of apoptosis: a chemoresistance factor or a hollow promise.
MedLine Citation:
PMID:  20682709     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
The X-linked inhibitor of apoptosis (XIAP) is the only cellular protein that has evolved to potently inhibit the enzymatic activity of mammalian caspases and promotes resistance to apoptosis. Given its role in apoptosis and its frequently elevated expression in malignant cells, XIAP has garnered the most attention as a promising therapeutic target in cancer to overcome drug resistance. Accordingly, XIAP is thought to render tumor cells resistant to chemotherapy through its ability to inhibit caspases, and it is on this basis that XIAP has been proposed as an important adverse biomarker for chemoresistance in cancer patients. Here, the current understanding of the role of XIAP in cancer is reviewed. Further, the notion is explored that the elevated XIAP expression frequently observed in malignant tissues is, at least, not exclusively responsible for the resistance of tumor cells to conventional therapeutic treatment; rather, the function of XIAP seems to be conducive to the process of malignant transformation and/or progression.
Authors:
Hamid Kashkar
Related Documents :
16133869 - Spodoptera littoralis caspase-1, a lepidopteran effector caspase inducible by apoptotic...
17265069 - Caspase-9-dependent pathway to murine germ cell apoptosis: mediation by oxidative stres...
10103059 - Cleavage of transcription factor sp1 by caspases during anti-igm-induced b-cell apoptosis.
9531309 - Activation of caspase 3 (cpp32)-like proteases is essential for tnf-alpha-induced hepat...
10225139 - Regulation of caspase activation in apoptosis: implications in pathogenesis and treatme...
9056419 - Inhibition of ice-related proteases (caspases) and nuclear apoptosis by phenylarsine ox...
10417669 - Salivary gland extract from ixodes ricinus ticks inhibits production of interferon-gamm...
22111529 - Role of arginase in asthma: potential clinical applications.
7544909 - Macrophage response to microbial pathogens: modulation of the expression of adhesion, c...
Publication Detail:
Type:  Journal Article; Research Support, Non-U.S. Gov't; Review     Date:  2010-08-03
Journal Detail:
Title:  Clinical cancer research : an official journal of the American Association for Cancer Research     Volume:  16     ISSN:  1078-0432     ISO Abbreviation:  Clin. Cancer Res.     Publication Date:  2010 Sep 
Date Detail:
Created Date:  2010-09-16     Completed Date:  2011-02-02     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  9502500     Medline TA:  Clin Cancer Res     Country:  United States    
Other Details:
Languages:  eng     Pagination:  4496-502     Citation Subset:  IM    
Copyright Information:
©2010 AACR.
Affiliation:
Institute for Medical Microbiology, Immunology and Hygiene, University of Cologne, Köln, Germany. h.kashkar@uni-koeln.de
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Animals
Antineoplastic Agents / therapeutic use
Cell Transformation, Neoplastic / genetics
Drug Resistance, Neoplasm / genetics*
Humans
Models, Biological
Molecular Targeted Therapy / methods*,  trends
Neoplasms / drug therapy*,  genetics
Therapies, Investigational / methods,  trends
Translational Research / methods,  trends
X-Linked Inhibitor of Apoptosis Protein / antagonists & inhibitors,  genetics,  metabolism,  physiology*
Chemical
Reg. No./Substance:
0/Antineoplastic Agents; 0/X-Linked Inhibitor of Apoptosis Protein

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  An open-label, phase I study of the polo-like kinase-1 inhibitor, BI 2536, in patients with advanced...
Next Document:  Inhibition of hypoxia inducible factor-1alpha by dihydroxyphenylethanol, a product from olive oil, b...